Literature DB >> 19232380

Modulation of connexin 43 in rotenone-induced model of Parkinson's disease.

A Kawasaki1, T Hayashi, K Nakachi, J E Trosko, K Sugihara, Y Kotake, S Ohta.   

Abstract

Gap junctional communication plays an important role in various models of brain pathology, but the changes of gap junctions in Parkinsonism are still not understood. In this study, we show that a major gap junctional protein, connexin43 (Cx43), in astrocytes is enhanced both in a rat Parkinson's disease (PD) model induced with rotenone, a widely used pesticide that inhibits mitochondrial complex I, and in vitro in cultured astrocytes stimulated with rotenone. Enhancement of Cx43 protein levels in rotenone-treated cultured astrocytes occurred in parallel with an increase in gap junctional intercellular communication, but was not accompanied with an increase in Cx43 mRNA levels. Furthermore, the rotenone-induced increase of Cx43 protein levels both in vitro and in vivo was associated with increased levels of phosphorylated Cx43, which is required for gap junctional intercellular communication. In our rat PD model, phosphorylated Cx43 was selectively enhanced in the basal ganglia regions, which contain DA neurons or their terminal areas. The increase of Cx43 levels was lower in the substantia nigra pars compacta and the striatum than in the substantia nigra pars reticulata and the globus pallidus. Our findings indicate that modulation of Cx43 protein, and consequently gap junctional cellular communication, in astrocytes may play an important role in PD pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232380     DOI: 10.1016/j.neuroscience.2009.01.080

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

Review 1.  Gap junction channels as potential targets for the treatment of major depressive disorder.

Authors:  Qian Ren; Zhen-Zhen Wang; Shi-Feng Chu; Cong-Yuan Xia; Nai-Hong Chen
Journal:  Psychopharmacology (Berl)       Date:  2017-11-25       Impact factor: 4.530

Review 2.  The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system.

Authors:  Eliseo A Eugenin; Daniel Basilio; Juan C Sáez; Juan A Orellana; Cedric S Raine; Feliksas Bukauskas; Michael V L Bennett; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-23       Impact factor: 4.147

Review 3.  Brain Disorders and Chemical Pollutants: A Gap Junction Link?

Authors:  Marc Mesnil; Norah Defamie; Christian Naus; Denis Sarrouilhe
Journal:  Biomolecules       Date:  2020-12-31

4.  Reversal of rotenone-induced dysfunction of astrocytic connexin43 by opening mitochondrial ATP-sensitive potassium channels.

Authors:  Shu Zhang; Rui Liang; Fang Zhou; Xu Huang; Jian-Hua Ding; Gang Hu
Journal:  Cell Mol Neurobiol       Date:  2010-09-08       Impact factor: 5.046

5.  [Inhibition connexin 43 by mimetic peptide Gap27 mediates protective effects on 6-hydroxydopamine induced Parkinson's disease mouse model].

Authors:  H H Quan; W X Xu; Y Z Qi; Q R Li; H Zhou; J Huang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-06-18

6.  Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson's disease.

Authors:  Poonam Thakur; Bimla Nehru
Journal:  Mol Neurobiol       Date:  2014-06-20       Impact factor: 5.590

Review 7.  Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.

Authors:  Madeline Halpern; Kristen J Brennand; James Gregory
Journal:  Neurobiol Dis       Date:  2019-08-02       Impact factor: 5.996

8.  Amitriptyline up-regulates connexin43-gap junction in rat cultured cortical astrocytes via activation of the p38 and c-Fos/AP-1 signalling pathway.

Authors:  N Morioka; K Suekama; F F Zhang; N Kajitani; K Hisaoka-Nakashima; M Takebayashi; Y Nakata
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

9.  Connexin43 promotes angiogenesis through activating the HIF-1α/VEGF signaling pathway under chronic cerebral hypoperfusion.

Authors:  Weiwei Yu; Haiqiang Jin; Wei Sun; Ding Nan; Jianwen Deng; Jingjing Jia; Zemou Yu; Yining Huang
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-25       Impact factor: 6.200

10.  Limiting transport steps and novel interactions of Connexin-43 along the secretory pathway.

Authors:  Irina V Majoul; Daria Onichtchouk; Eugenia Butkevich; Dirk Wenzel; Levon M Chailakhyan; Rainer Duden
Journal:  Histochem Cell Biol       Date:  2009-07-22       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.